(Q53101024)

English

Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.

scientific article published on 14 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

chemoradiotherapy

0 references

0 references

Rodney J. Hicks

12

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

9

object named as

David Binns

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

3

object named as

Danny Rischin

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

author name string

Mateya E Trinkaus

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Rob Blum

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Jason Callahan

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Mathias Bressel

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Tatiana Segard

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Peter Roselt

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Peter Eu

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Michael P MacManus

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

David Ball

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

publication date

14 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Journal of Medical Imaging and Radiation Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

57

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

475-481

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Drug resistance and the solid tumor microenvironment

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Hypoxia in models of lung cancer: implications for targeted therapeutics

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1111%2F1754-9485.12086

21 January 2018

Identifiers

10.1111/1754-9485.12086

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23870348

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53101024&oldid=2109540710"